CLINICAL_TRIALS
trial_result
· 2012-04-10
Clinical Trial Update: AZD7268 Safety and Tolerability Study [Phase 2]
Summary
Phase 2 safety and tolerability study of AZD7268 in major depressive disorder has been completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2012-04-10